Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

TNS Energo Yaroslavl reported for 9 months of 2024 by RAS

11/2/24 YRSB

TNS Energo Nizhny Novgorod reported for 9 months of 2024 by RAS

11/2/24 NNSB

Kamaz reported for 9 months of 2024 by RAS

11/2/24 KMAZ

TNS Energy Kuban reported for 9 months of 2024 by RAS

11/2/24 KBSB

Sollers reported for 9 months of 2024 by RAS

11/2/24 SVAV

Buryatzoloto reported for 9 months of 2024 by RAS

11/2/24 BRZL

Chelyabinsk Metallurgical Plant reported for 9 months of 2024 by RAS

11/2/24 CHKZ

Sistema reported for 9 months of 2024 by RAS

11/2/24 AFKS

Lenta opened the first darkstore in St. Petersburg

11/1/24 LENT

El5-Energo reported for 9 months of 2024 under RAS

11/1/24 ELFV